Are Drug Prices Driving Healthcare Cost Growth?

This report illustrates that state policy and legislative recommendations requiring pharmaceutical companies to disclose proprietary information would discourage the development of new innovative medicines, lead to higher healthcare costs over the long term, and potentially damage a big driver of Massachusetts’ business economy.

Download Report: Are Drug Prices Driving Healthcare Cost Growth?